Uiwang-si, South Korea

Heesup Shin

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Heesup Shin: Innovating Schizophrenia Drug Testing with Knockout Mouse Models

Introduction: Heesup Shin, an accomplished inventor located in Uiwang-si, South Korea, has made significant strides in the field of biomedical research. With a focus on developing innovative methods for drug testing, Shin has contributed to the understanding of schizophrenia through his groundbreaking work.

Latest Patents: Heesup Shin holds a patent for the invention titled "Phospholipase C β1 (PLCβ1) knockout mice as a model system for testing schizophrenia drugs". This patent describes a method for screening therapeutic drugs for schizophrenia using an animal model that exhibits major symptoms of the disease. The PLCβ1 knockout mice developed by Shin display symptoms similar to those observed in human patients, including locomotor hyperactivity, impaired prepulse inhibition, and socially subordinate status. These mice serve as a valuable resource for researchers aiming to test new therapeutic interventions against schizophrenia.

Career Highlights: Shin is affiliated with the Korea Institute of Science and Technology, where he engages in advanced research focused on neurological disorders. His innovative approach to creating an animal model for schizophrenia has paved the way for more effective drug screening methodologies and has important implications for future therapeutic strategies.

Collaborations: Throughout his career, Shin has collaborated with notable colleagues such as Hae-Young Koh and Daesoo Kim. These collaborations have contributed to the successful development and validation of the knockout mouse model, which holds potential for further understanding and treating schizophrenia.

Conclusion: Heesup Shin's contributions to the field of schizophrenia research, particularly through his patented knockout mouse model, exemplify the importance of innovation in biomedical science. His work not only enhances drug screening techniques but also offers hope for more effective treatments for individuals affected by schizophrenia. As he continues his research at the Korea Institute of Science and Technology, Shin remains a prominent figure in the quest for groundbreaking therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…